Quantbot Technologies LP Buys 151,610 Shares of Nutrien Ltd. $NTR

Quantbot Technologies LP boosted its position in shares of Nutrien Ltd. (NYSE:NTR) by 251.2% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 211,959 shares of the company’s stock after purchasing an additional 151,610 shares during the quarter. Quantbot Technologies LP’s holdings in Nutrien were worth $12,444,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Root Financial Partners LLC bought a new stake in shares of Nutrien in the third quarter valued at about $37,000. Huntington National Bank raised its holdings in shares of Nutrien by 72.6% in the 2nd quarter. Huntington National Bank now owns 656 shares of the company’s stock valued at $38,000 after purchasing an additional 276 shares in the last quarter. Geneos Wealth Management Inc. lifted its position in shares of Nutrien by 42.4% in the 2nd quarter. Geneos Wealth Management Inc. now owns 735 shares of the company’s stock worth $43,000 after purchasing an additional 219 shares during the period. Acadian Asset Management LLC bought a new position in shares of Nutrien during the first quarter valued at approximately $54,000. Finally, Bessemer Group Inc. boosted its stake in shares of Nutrien by 27.7% during the third quarter. Bessemer Group Inc. now owns 937 shares of the company’s stock valued at $55,000 after purchasing an additional 203 shares in the last quarter. Institutional investors own 63.10% of the company’s stock.

Nutrien Trading Up 2.7%

Shares of NYSE:NTR opened at $75.07 on Friday. Nutrien Ltd. has a 52-week low of $45.78 and a 52-week high of $75.73. The company has a quick ratio of 0.70, a current ratio of 1.34 and a debt-to-equity ratio of 0.37. The stock has a market cap of $36.12 billion, a price-to-earnings ratio of 16.11 and a beta of 0.73. The business has a 50-day moving average price of $67.31 and a 200-day moving average price of $61.21.

Nutrien (NYSE:NTR) last issued its quarterly earnings data on Wednesday, February 18th. The company reported $0.83 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.87 by ($0.04). The company had revenue of $5.12 billion during the quarter, compared to analyst estimates of $5.26 billion. Nutrien had a net margin of 8.43% and a return on equity of 8.41%. The business’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same period last year, the firm earned $0.31 EPS. Equities analysts predict that Nutrien Ltd. will post 3.72 EPS for the current year.

Nutrien Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, April 16th. Investors of record on Tuesday, March 31st will be paid a $0.55 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $2.20 dividend on an annualized basis and a yield of 2.9%. This is an increase from Nutrien’s previous quarterly dividend of $0.55. Nutrien’s dividend payout ratio is 46.78%.

Wall Street Analysts Forecast Growth

NTR has been the subject of a number of recent research reports. Oppenheimer boosted their price objective on shares of Nutrien from $76.00 to $78.00 and gave the stock an “outperform” rating in a research note on Thursday. UBS Group boosted their price target on Nutrien from $58.00 to $63.00 and gave the stock a “neutral” rating in a research report on Monday, January 12th. TD Securities raised their price objective on Nutrien from $80.00 to $81.00 and gave the company a “buy” rating in a research report on Tuesday, February 17th. Jefferies Financial Group lifted their target price on Nutrien from $60.00 to $74.00 and gave the company a “hold” rating in a research note on Monday. Finally, Zacks Research upgraded shares of Nutrien from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 27th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $72.24.

About Nutrien

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.